JLB is a peer-reviewed, academic journal published by the Society for Leukocyte Biology for its members and the community of immunobiologists. The journal publishes papers devoted to the exploration of the cellular and molecular biology of granulocytes, mononuclear phagocytes, lymphocytes, NK cells, and other cells involved in host physiology and defense/resistance against disease.
December 2017: Frontline Science
On matters of maturity, self-control, and responsiveness: inhibitory NK receptors in the driver’s seat?
Stressing out mast cells via CRF1
Countering immune regulation: sTim-ulating SLE disease pathogenesis
Spotlight on Leading Edge Research
A hyporesponsive subset of rat NK cells negative for Ly49s3 and NKR-P1B are precursors to the functionally mature NKR-P1B+ subset
Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology
Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE
Hypothesis: stimulation of trained immunity as adjunctive immunotherapy in cancer
The role of halofuginone in fibrosis: more to be explored?
Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy
Please log into Portfolio
to slb.memberclicks.net for access) (Note: you will be redirected
Welcome to JLB Video
No Manuscript Submission Fee
Average Time to First Decision: 23 Days
In the Top 25% of Cited Hematology Journals
In the Top 25% of Cited Immunology Journals
Average Monthly Web Hits: 333,142